Chris Tyler

Chris Tyler

Chris Tyler, a Wall Street veteran of more than 20 years, began his career in the financial markets working on the trading floor of the AMEX in New York as an equity option market maker at Interactive Brokers’ floor trading unit Timber Hill LLC.

After moving to San Francisco to make markets on the P-Coast exchange during the dot-com craze and spending nearly a decade working in names like Philip Morris, Seagate and Compaq, Chris hung up his smock and trading badge, but not his passion for options and the markets.

Since exiting the floor, and for the better part of the past dozen years, Chris has worked as an option and market strategist, writing analyses for Trading Markets, Charles Schwab subsidiary Optionetics and as a featured columnist at Investor’s Business Daily.

Aside from offering his trading insights at InvestorPlace.com, Chris is currently studying for his Accredited Portfolio Management Advisor (APMA) designation, manages investments for closely held accounts and offers his services as an investment strategist to GLJ Advisors, a CA based RIA.

Chris, his wife and blue heeler live in the Pacific NW. And if you can’t follow him around in your own VW Vanagon or Westfalia, feel free to follow him on Twitter via @Options_CAT.

Recent Articles

Amgen, Inc.: Buy This Pullback in Amgen Stock (AMGN)

Amgen stock is yet again facing a bout of bearishness, but this time, traders can look at this pullback from a bullish perspective.

Michael Kors Holdings Ltd: Get Cozy With KORS Stock

Following OK earnings and decent fundamental and technical support, Michael Kors stock is a better buy for income-generating trades.

US Oil Fund ETF: Profit in Either Direction Using a Long Strangle

Take the driver’s seat directionally and profit from either a large up or down move in USO with a long strangle.

Under Armour Inc: Make a Full-Court Press on UA Stock

Under Armour (UA) is overdue for a correction. Here's the best way to participate in a downside turn in UA stock.

Valeant: Profit From More Downside With a VRX Bear Put Spread

Short Valeant Pharmaceuticals with a bear put spread as bulls try in vain to defend a damaged VRX stock.